GW

GW Vitek CO.,LTD.

Specializes in biotechnology solutions and scientific instruments for R&D.

036180 | KO

Overview

Corporate Details

ISIN(s):
KR7036180008
LEI:
Country:
South Korea
Address:
서울특별시 금천구 벚꽃로 244 1101호(가산동, 벽산디지털밸리5차), 서울특별시

Description

GW Vitek CO.,LTD. is a company specializing in biotechnology solutions and scientific instruments for research and development. The company operates through two primary segments. The Bio Business division focuses on the development, manufacturing, and sale of bio-related products, including research antibodies and comprehensive biotechnology solutions. The Scientific Equipment division provides a wide range of laboratory instruments and consumables. Key product areas include imaging systems, chromatography equipment and consumables, general laboratory products, and tools for metabolic analysis. GW Vitek aims to supply researchers with optimal solutions to support the entire workflow for R&D and quality control analysis across various industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-26 00:00
주요사항보고서(유형자산양수결정)
Korean 12.8 KB
2024-02-22 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 57.8 KB
2024-02-21 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 36.1 KB
2024-02-19 00:00
불성실공시법인지정예고 (공시변경)
Korean 4.9 KB
2024-02-16 00:00
단기차입금증가결정
Korean 10.1 KB
2024-02-02 00:00
[기재정정]주주명부폐쇄기간또는기준일설정
Korean 11.7 KB
2024-02-02 00:00
[기재정정]주주총회소집결의(임시주주총회)
Korean 15.5 KB
2024-01-31 00:00
주식등의대량보유상황보고서(일반)
Korean 98.6 KB
2024-01-31 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2024-01-31 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 36.2 KB
2024-01-29 00:00
[기재정정]주요사항보고서(자기전환사채매도결정)
Korean 26.4 KB
2024-01-29 00:00
[기재정정]주요사항보고서(타법인주식및출자증권양도결정)
Korean 21.9 KB
2024-01-19 00:00
횡령ㆍ배임혐의진행사항
Korean 11.8 KB
2024-01-19 00:00
기타시장안내(횡령·배임 진행사항 관련 안내)
Korean 2.8 KB
2024-01-17 00:00
[기재정정]주주총회소집결의(임시주주총회)
Korean 16.1 KB

Automate Your Workflow. Get a real-time feed of all GW Vitek CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GW Vitek CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GW Vitek CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.